Reagents required to pre screen blood products for donation.
Ended Awarded
- Contract number
- HT009025FG30037
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $73,653
Award facts
- Contract value 100% obligated
- $73,653.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Chicago, IL 60064, USA
Award details come from SAM.gov/FPDS.
About this award
Abbott Laboratories Inc., through its Abbott Diagnostics Division, has been awarded a Blanket Purchase Agreement (BPA) call valued at $73,653.12 by the Defense Health Agency to supply reagents required for pre-screening blood products for donation. The contract, awarded on August 27, 2025, with a completion date of September 30, 2025, utilizes a firm fixed-price contract type and will be performed in North Chicago, Illinois. This award was made without a set-aside designation, indicating full and open competition. The BPA call mechanism enables the Defense Health Agency to efficiently procure specialized diagnostic reagents from Abbott's established contract vehicle, streamlining the procurement process for critical blood screening materials needed to support military healthcare operations.
Abbott Laboratories is a well-established supplier of medical diagnostic products to federal healthcare agencies, including the Defense Health Agency, Department of Veterans Affairs, and Indian Health Service. The company maintains multiple significant indefinite delivery vehicles and BPAs across various federal agencies, particularly focused on providing clinical laboratory testing capabilities, immunoassay analyzers, and associated consumables. This specific reagent procurement supports the Defense Health Agency's blood product pre-screening operations, contributing to the safety and efficacy of blood transfusion services within the military healthcare system.
Quick answers
Who was awarded contract HT009025FG30037?
HT009025FG30037 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on August 27, 2025.
How much is contract HT009025FG30037 worth?
The government has obligated $73,653 on HT009025FG30037.
Is contract HT009025FG30037 an order under another contract?
Yes. HT009025FG30037 is a BPA call under FA301624A0044, a blanket purchase agreement.
Was contract HT009025FG30037 competed?
The extent of competition for HT009025FG30037 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award